Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 3/2015

01-06-2015 | Research Article

Consumers’ perception of generic substitution in Iran

Authors: Nazila Yousefi, Gholamhossein Mehralian, Farzad Peiravian, Samaneh NourMohammadi

Published in: International Journal of Clinical Pharmacy | Issue 3/2015

Login to get access

Abstract

Background The growth of pharmaceutical expenditure and patients’ out of pocket has motivated policy makers to encourage patients to substitution of brands medicines with their generic alternatives called generic substitution. Objectives As the patients are final decision makers to accept generic substitution, the aim of this study is to evaluate the patient perception about generic medicines and underlying factors which can promote the generic acceptance. Setting The study was done in community pharmacies in Tehran, the capital city of Iran. Method A cross-sectional descriptive study inviting people purchasing their drug at community pharmacies were per-formed using a self-administrated anonymous questionnaire (N=1309). Main outcomes measures besides the demographic section, 16 items of developed questionnaire were categorized to five main factors including: patients’ perception about efficiency, safety and cost of generic medicines, patient trust on physicians and pharmacists’ advice. Results Findings of completed questionnaires showed among the aforementioned factors the physician has the first priority to encourage patients to use of generics medicines which followed respectively by pharmacist’s role, cost of medicines, efficacy, and safety concerns. Conclusion In conclusion, the trust of Iranian’s society on the physicians and pharmacists advice would create a credible opportunity to reduce pharmaceutical expenditures as well as patients’ out of pocket by promotion of generic substitution.
Literature
1.
go back to reference Thomas R. Health services demand and utilization. Health services planning. New York, US: Springer; 2003.CrossRef Thomas R. Health services demand and utilization. Health services planning. New York, US: Springer; 2003.CrossRef
2.
go back to reference Smith RD, Correa C, Oh C. Trade, TRIPS and Pharmaceuticals. Lancet 2009;373:684–91. Smith RD, Correa C, Oh C. Trade, TRIPS and Pharmaceuticals. Lancet 2009;373:684–91.
3.
go back to reference Ess SM, Schneeweiss S, Szucs TD. European healthcare policies for controlling drug expenditure. Pharmacoeconomics. 2003;21(2):89–103.CrossRefPubMed Ess SM, Schneeweiss S, Szucs TD. European healthcare policies for controlling drug expenditure. Pharmacoeconomics. 2003;21(2):89–103.CrossRefPubMed
4.
go back to reference McManus P, Birkett DJ, Dudley J, Stevens A. Impact of the Minimum Pricing Policy and introduction of brand (generic) substitution into the Pharmaceutical Benefits Scheme in Australia. Pharmacoepidemiol Drug Saf. 2001;10(4):295–300.CrossRefPubMed McManus P, Birkett DJ, Dudley J, Stevens A. Impact of the Minimum Pricing Policy and introduction of brand (generic) substitution into the Pharmaceutical Benefits Scheme in Australia. Pharmacoepidemiol Drug Saf. 2001;10(4):295–300.CrossRefPubMed
5.
go back to reference Hassali MA, Shafie AA, Chong CP, Saleem F, Atif M, Chua G, et al. Community pharmacist’s perceptions towards the quality of locally manufactured generic medicines: a descriptive study from Malaysia. J Appl Pharm Sci. 2012;2(1):56–60. Hassali MA, Shafie AA, Chong CP, Saleem F, Atif M, Chua G, et al. Community pharmacist’s perceptions towards the quality of locally manufactured generic medicines: a descriptive study from Malaysia. J Appl Pharm Sci. 2012;2(1):56–60.
6.
go back to reference Abdollahiasl A. Medicine prices, availability, affordability and price component. In: IranFDO, editor. World Health Organization; 2010. Abdollahiasl A. Medicine prices, availability, affordability and price component. In: IranFDO, editor. World Health Organization; 2010.
8.
go back to reference Jamshed S, Babar Z, Ibrahim M, Hassali M. Generic medicines as a way to improve access and affordability: a proposed framework for Pakistan. J Clin Diagn Res. 2009;3(3):1596–600. Jamshed S, Babar Z, Ibrahim M, Hassali M. Generic medicines as a way to improve access and affordability: a proposed framework for Pakistan. J Clin Diagn Res. 2009;3(3):1596–600.
9.
go back to reference Omojasola A, Hernandez M, Sansgiry S, Jones L. Perception of generic prescription drugs and utilization of generic drug discount programs. Ethn Dis. 2012;22(4):479.PubMedCentralPubMed Omojasola A, Hernandez M, Sansgiry S, Jones L. Perception of generic prescription drugs and utilization of generic drug discount programs. Ethn Dis. 2012;22(4):479.PubMedCentralPubMed
10.
go back to reference Galizzi MM, Ghislandi S, Miraldo M. Effects of reference pricing in pharmaceutical markets. Pharmacoeconomics. 2011;29(1):17–33.CrossRefPubMed Galizzi MM, Ghislandi S, Miraldo M. Effects of reference pricing in pharmaceutical markets. Pharmacoeconomics. 2011;29(1):17–33.CrossRefPubMed
11.
go back to reference Mendis S, Fukino K, Cameron A, Laing R, Filipe A Jr, Khatib O, et al. The availability and affordability of selected essential medicines for chronic diseases in six low-and middle-income countries. Bull World Health Organ. 2007;85(4):279–88.CrossRefPubMedCentralPubMed Mendis S, Fukino K, Cameron A, Laing R, Filipe A Jr, Khatib O, et al. The availability and affordability of selected essential medicines for chronic diseases in six low-and middle-income countries. Bull World Health Organ. 2007;85(4):279–88.CrossRefPubMedCentralPubMed
12.
go back to reference Barros PP, Nunes LC. The impact of pharmaceutical policy measures: an endogenous structural-break approach. Soc Sci Med. 2010;71(3):440–50.CrossRefPubMed Barros PP, Nunes LC. The impact of pharmaceutical policy measures: an endogenous structural-break approach. Soc Sci Med. 2010;71(3):440–50.CrossRefPubMed
13.
go back to reference Chong CP, March G, Clark A, Gilbert A, Hassali MA, Bahari MB. A nationwide study on generic medicines substitution practices of Australian community pharmacists and patient acceptance. Health Policy. 2011;99(2):139–48.CrossRefPubMed Chong CP, March G, Clark A, Gilbert A, Hassali MA, Bahari MB. A nationwide study on generic medicines substitution practices of Australian community pharmacists and patient acceptance. Health Policy. 2011;99(2):139–48.CrossRefPubMed
14.
go back to reference Babar Z-U-D, Stewart J, Reddy S, Alzaher W, Vareed P, Yacoub N, et al. An evaluation of consumers’ knowledge, perceptions and attitudes regarding generic medicines in Auckland. Pharm World Sci. 2010;32(4):440–8.CrossRefPubMed Babar Z-U-D, Stewart J, Reddy S, Alzaher W, Vareed P, Yacoub N, et al. An evaluation of consumers’ knowledge, perceptions and attitudes regarding generic medicines in Auckland. Pharm World Sci. 2010;32(4):440–8.CrossRefPubMed
15.
go back to reference Sharrad AK, Hassali MA. Consumer perception on generic medicines in Basrah, Iraq: preliminary findings from a qualitative study. Res Soc Adm Pharm. 2011;7(1):108–12.CrossRef Sharrad AK, Hassali MA. Consumer perception on generic medicines in Basrah, Iraq: preliminary findings from a qualitative study. Res Soc Adm Pharm. 2011;7(1):108–12.CrossRef
16.
go back to reference IranFDO. Pharmaceutical statistics. Food and drug organization of iranian Ministry of Health, Iran; 2013. IranFDO. Pharmaceutical statistics. Food and drug organization of iranian Ministry of Health, Iran; 2013.
17.
go back to reference Heikkilä R, Mäntyselkä P, Ahonen R. Why people refuse generic substitution: a population survey of public opinion on generic substitution in Finland. Drugs Ther Perspect. 2012;28(8):24–6. Heikkilä R, Mäntyselkä P, Ahonen R. Why people refuse generic substitution: a population survey of public opinion on generic substitution in Finland. Drugs Ther Perspect. 2012;28(8):24–6.
18.
go back to reference Cameron A, Mantel-Teeuwisse AK, Leufkens HG, Laing RO. Switching from originator brand medicines to generic equivalents in selected developing countries: How much could be saved? Value Health. 2012;15(5):664–73.CrossRefPubMed Cameron A, Mantel-Teeuwisse AK, Leufkens HG, Laing RO. Switching from originator brand medicines to generic equivalents in selected developing countries: How much could be saved? Value Health. 2012;15(5):664–73.CrossRefPubMed
19.
go back to reference Hassali MA, Shafie AA, Jamshed S, Ibrahim MI, Awaisu A. Consumers’ views on generic medicines: a review of the literature. Int J Pharm Pract. 2009;17(2):79–88.PubMed Hassali MA, Shafie AA, Jamshed S, Ibrahim MI, Awaisu A. Consumers’ views on generic medicines: a review of the literature. Int J Pharm Pract. 2009;17(2):79–88.PubMed
20.
go back to reference King DR, Kanavos P. Encouraging the use of generic medicines: implications for transition economies. Croat Med J. 2002;43(4):462–9.PubMed King DR, Kanavos P. Encouraging the use of generic medicines: implications for transition economies. Croat Med J. 2002;43(4):462–9.PubMed
21.
go back to reference Himmel W, Simmenroth-Nayda A, Niebling W, Ledig T, Jansen R-D, Kochen M, et al. What do primary care patients think about generic drugs? Int J Clin Pharmacol Ther. 2005;43(10):472.CrossRefPubMed Himmel W, Simmenroth-Nayda A, Niebling W, Ledig T, Jansen R-D, Kochen M, et al. What do primary care patients think about generic drugs? Int J Clin Pharmacol Ther. 2005;43(10):472.CrossRefPubMed
22.
go back to reference Kjoenniksen I, Lindbaek M, Granas AG. Patients’ attitudes towards and experiences of generic drug substitution in Norway. Pharm World Sci. 2006;28(5):284–9.CrossRefPubMed Kjoenniksen I, Lindbaek M, Granas AG. Patients’ attitudes towards and experiences of generic drug substitution in Norway. Pharm World Sci. 2006;28(5):284–9.CrossRefPubMed
23.
go back to reference Meredith PA. Potential concerns about generic substitution: bioequivalence versus therapeutic equivalence of different amlodipine salt forms. Curr Med Res Opin. 2009;25(9):2179–89.CrossRefPubMed Meredith PA. Potential concerns about generic substitution: bioequivalence versus therapeutic equivalence of different amlodipine salt forms. Curr Med Res Opin. 2009;25(9):2179–89.CrossRefPubMed
24.
go back to reference Quintal C, Mendes P. Underuse of generic medicines in Portugal: an empirical study on the perceptions and attitudes of patients and pharmacists. Health Policy. 2012;104(1):61–8.CrossRefPubMed Quintal C, Mendes P. Underuse of generic medicines in Portugal: an empirical study on the perceptions and attitudes of patients and pharmacists. Health Policy. 2012;104(1):61–8.CrossRefPubMed
25.
go back to reference Heikkilä R, Mäntyselkä P, Ahonen R. Do people regard cheaper medicines effective? Population survey on public opinion of generic substitution in Finland. Pharmacoepidemiol Drug Saf. 2011;20(2):185–91.CrossRefPubMed Heikkilä R, Mäntyselkä P, Ahonen R. Do people regard cheaper medicines effective? Population survey on public opinion of generic substitution in Finland. Pharmacoepidemiol Drug Saf. 2011;20(2):185–91.CrossRefPubMed
26.
go back to reference Heikkilä R, Mäntyselkä P, Hartikainen-Herranen K, Ahonen R. Customers’ and physicians’ opinions of and experiences with generic substitution during the first year in Finland. Health Policy. 2007;82(3):366–74.CrossRefPubMed Heikkilä R, Mäntyselkä P, Hartikainen-Herranen K, Ahonen R. Customers’ and physicians’ opinions of and experiences with generic substitution during the first year in Finland. Health Policy. 2007;82(3):366–74.CrossRefPubMed
27.
go back to reference Heikkilä R, Mäntyselkä P, Ahonen R. Price, familiarity, and availability determine the choice of drug-a population-based survey five years after generic substitution was introduced in Finland. BMC Pharmacol Toxicol. 2011;11(1):20. Heikkilä R, Mäntyselkä P, Ahonen R. Price, familiarity, and availability determine the choice of drug-a population-based survey five years after generic substitution was introduced in Finland. BMC Pharmacol Toxicol. 2011;11(1):20.
28.
go back to reference Lambert ZV, Doering PL, Goldstein E, McCormick WC. Predispositions toward generic drug acceptance. J Consum Res. 1980;7(1):14–23. Lambert ZV, Doering PL, Goldstein E, McCormick WC. Predispositions toward generic drug acceptance. J Consum Res. 1980;7(1):14–23.
29.
go back to reference Gaither CA, Kirking DM, Ascione FJ, Welage LS. Science & practice-reviews-consumers’ views on generic medications. J Am Pharm Assoc. 2001;41(5):729–36. Gaither CA, Kirking DM, Ascione FJ, Welage LS. Science & practice-reviews-consumers’ views on generic medications. J Am Pharm Assoc. 2001;41(5):729–36.
30.
go back to reference Rathe J, Larsen P, Andersen M, Paulsen M, Jarbøl D, Thomsen J, et al. Associations between generic substitution and patients’ attitudes, beliefs and experiences. Eur J Clin Pharmacol. 2013;69(10):1827–36.CrossRefPubMed Rathe J, Larsen P, Andersen M, Paulsen M, Jarbøl D, Thomsen J, et al. Associations between generic substitution and patients’ attitudes, beliefs and experiences. Eur J Clin Pharmacol. 2013;69(10):1827–36.CrossRefPubMed
31.
go back to reference Allenet B, Barry H. Opinion and behaviour of pharmacists towards the substitution of branded drugs by generic drugs: survey of 1,000 French community pharmacists. Pharm World Sci. 2003;25(5):197–202.CrossRefPubMed Allenet B, Barry H. Opinion and behaviour of pharmacists towards the substitution of branded drugs by generic drugs: survey of 1,000 French community pharmacists. Pharm World Sci. 2003;25(5):197–202.CrossRefPubMed
32.
go back to reference Shepherd M. Consumer drug purchases are based on perceptions of quality, survey on generics finds. Am J Hosp Pharm. 1988;45:1245. Shepherd M. Consumer drug purchases are based on perceptions of quality, survey on generics finds. Am J Hosp Pharm. 1988;45:1245.
33.
go back to reference Al-Gedadi NA, Hassali MA, Shafie AA. A pilot survey on perceptions and knowledge of generic medicines among consumers in Penang, Malaysia. Pharm Pract. 2008;6(2):93–7. Al-Gedadi NA, Hassali MA, Shafie AA. A pilot survey on perceptions and knowledge of generic medicines among consumers in Penang, Malaysia. Pharm Pract. 2008;6(2):93–7.
34.
go back to reference Figueiras MJ, Marcelino D, Cortes MA. People’s views on the level of agreement of generic medicines for different illnesses. Pharm World Sci. 2008;30(5):590–4.CrossRefPubMed Figueiras MJ, Marcelino D, Cortes MA. People’s views on the level of agreement of generic medicines for different illnesses. Pharm World Sci. 2008;30(5):590–4.CrossRefPubMed
35.
go back to reference Ganther JM, Kreling DH. Consumer perceptions of risk and required cost savings for generic prescription drugs. Am Pharm. 1999;40(3):378–83. Ganther JM, Kreling DH. Consumer perceptions of risk and required cost savings for generic prescription drugs. Am Pharm. 1999;40(3):378–83.
36.
go back to reference Mehralian G, Rangchian M, Rasekh HR. Client priorities and satisfaction with community pharmacies: the situation in Tehran. Int J Clin Pharm. 2014;36(4):707–15.CrossRefPubMed Mehralian G, Rangchian M, Rasekh HR. Client priorities and satisfaction with community pharmacies: the situation in Tehran. Int J Clin Pharm. 2014;36(4):707–15.CrossRefPubMed
37.
go back to reference Mehralian G, Rangchian M, Javadi A, Peiravian F. Investigation on barriers to pharmaceutical care in community pharmacies: a structural equation model. Int J Clin Pharm. 2014;36(5):1087–94. Mehralian G, Rangchian M, Javadi A, Peiravian F. Investigation on barriers to pharmaceutical care in community pharmacies: a structural equation model. Int J Clin Pharm. 2014;36(5):1087–94.
38.
go back to reference Mehralian G, Yousefi N, Hashemian F, Maleksabet H. knowledge, attitude and practice regarding dietary supplements: a community pharmacy-based survey in Tehran. Iran J Pharm Res. 2014;13(4):1455–63. Mehralian G, Yousefi N, Hashemian F, Maleksabet H. knowledge, attitude and practice regarding dietary supplements: a community pharmacy-based survey in Tehran. Iran J Pharm Res. 2014;13(4):1455–63.
39.
go back to reference Ud-Din Babar Z, Grover P, Butler R, Bye L, Sheridan J. A qualitative evaluation of general practitioners’ perceptions regarding access to medicines in New Zealand. BMJ Open 2012;2:e000518PubMedCentralPubMed Ud-Din Babar Z, Grover P, Butler R, Bye L, Sheridan J. A qualitative evaluation of general practitioners’ perceptions regarding access to medicines in New Zealand. BMJ Open 2012;2:e000518PubMedCentralPubMed
Metadata
Title
Consumers’ perception of generic substitution in Iran
Authors
Nazila Yousefi
Gholamhossein Mehralian
Farzad Peiravian
Samaneh NourMohammadi
Publication date
01-06-2015
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 3/2015
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-015-0085-4

Other articles of this Issue 3/2015

International Journal of Clinical Pharmacy 3/2015 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.